NTLA-2001
Intellia Therapeutics
['cardio', 'cardiomyopathy', 'crispr']
 new #aha22 #lbct interview dr julian gillmore discusses exciting results demonstrating tolerability and efficacy of the ntla-2001 #crispr-cas9-based gene editing therapy in pts with #attr #amyloidosis with cardiomyopathy! 
?? Broadcast creators ?? Interview makers ??????? CME ?? Peer-reviewed journal publisher. Content posted intended for HCPs.